Source: Annals of Hepatology. Unidade: FM
Subjects: NEOPLASIAS HEPÁTICAS, CARCINOMA HEPATOCELULAR, EVENTO ADVERSO A MEDICAMENTO, MANIFESTAÇÕES CUTÂNEAS, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRANCO, Fernanda et al. The Impact of Early Dermatologic Events in the Survival of Patients with Hepatocellular Carcinoma Treated with Sorafenib. Annals of Hepatology, v. 16, n. 2, p. 263-268, 2017Tradução . . Disponível em: https://doi.org/10.5604/16652681.1231585. Acesso em: 18 nov. 2024.APA
Branco, F., Alencar, R. S. M., Volt, F., Sartori, G., Dode, A., Kikuchi, L., et al. (2017). The Impact of Early Dermatologic Events in the Survival of Patients with Hepatocellular Carcinoma Treated with Sorafenib. Annals of Hepatology, 16( 2), 263-268. doi:10.5604/16652681.1231585NLM
Branco F, Alencar RSM, Volt F, Sartori G, Dode A, Kikuchi L, Tani CM, Chagas AL, Pfiffer T, Hoff P, Carrilho FJ, Mattos AA de. The Impact of Early Dermatologic Events in the Survival of Patients with Hepatocellular Carcinoma Treated with Sorafenib [Internet]. Annals of Hepatology. 2017 ; 16( 2): 263-268.[citado 2024 nov. 18 ] Available from: https://doi.org/10.5604/16652681.1231585Vancouver
Branco F, Alencar RSM, Volt F, Sartori G, Dode A, Kikuchi L, Tani CM, Chagas AL, Pfiffer T, Hoff P, Carrilho FJ, Mattos AA de. The Impact of Early Dermatologic Events in the Survival of Patients with Hepatocellular Carcinoma Treated with Sorafenib [Internet]. Annals of Hepatology. 2017 ; 16( 2): 263-268.[citado 2024 nov. 18 ] Available from: https://doi.org/10.5604/16652681.1231585
